Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -NOK 31.7B, followed by BridgeBio Pharma (-NOK 20.3B) and Cytokinetics (-NOK 6.4B). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-NOK 31.7B
- Median
- NOK 8.5B
- Combined market value
- NOK 49.32T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -NOK 31.7B | NOK 4.95T | NOK 2,797.66 | 1.57% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -NOK 20.3B | NOK 146.7B | NOK 753.17 | 1.03% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -NOK 6.4B | NOK 69.2B | NOK 496.61 | 0.95% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -NOK 2B | NOK 48.9B | NOK 585.53 | 0.07% down | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -NOK 1.8B | NOK 171.8B | NOK 2,618.45 | 0.53% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -NOK 1.2B | NOK 51B | NOK 1,208.14 | 0.94% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -NOK 687.2M | NOK 72.8B | NOK 208.99 | 1.94% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | NOK 857.1M | NOK 68.1B | NOK 1,295.40 | 1.84% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | NOK 1.1B | NOK 46.8B | NOK 487.88 | 1.64% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.3B | NOK 78.5B | NOK 1,132.81 | 0.08% up | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | NOK 3.1B | NOK 57.7B | NOK 884.12 | 0.95% down | 31% up | ||
| 12 | ErascaERAS · Health Care | NOK 3.2B | NOK 45B | NOK 128.33 | 4.82% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | NOK 3.2B | NOK 37.9B | NOK 276.50 | 3.05% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 4.5B | NOK 59.4B | NOK 420.31 | 0.72% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | NOK 4.6B | NOK 63.6B | NOK 937.21 | 0.24% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | NOK 4.7B | NOK 44.2B | NOK 265.24 | 1.35% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | NOK 4.8B | NOK 47.2B | NOK 838.49 | 0.69% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | NOK 4.9B | NOK 71.1B | NOK 811.90 | 1.88% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.1B | NOK 43.4B | NOK 396.44 | 2.85% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 5.5B | NOK 73.3B | NOK 932.85 | 1.04% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 5.9B | NOK 92.4B | NOK 3,977.84 | 2.89% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | NOK 6B | NOK 78.9B | NOK 1,209.01 | 0.10% down | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | NOK 6.2B | NOK 48B | NOK 275.73 | 1.99% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | NOK 6.3B | NOK 72.5B | NOK 662.60 | 2.58% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | NOK 6.3B | NOK 94.7B | NOK 626.54 | 2.93% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | NOK 6.4B | NOK 83.1B | NOK 103.91 | 0.33% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | NOK 6.9B | NOK 87.8B | NOK 924.01 | 1.47% up | 286% up | ||
| 28 | InsmedINSM · Health Care | NOK 7.2B | NOK 255.6B | NOK 1,164.89 | 1.52% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | NOK 7.5B | NOK 62.7B | NOK 1,544.97 | 0.91% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | NOK 7.7B | NOK 198.8B | NOK 1,484.11 | 2.31% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | NOK 8.5B | NOK 82.7B | NOK 2,957.63 | 0.12% down | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | NOK 9.7B | NOK 30.6B | NOK 157.64 | 0.81% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | NOK 9.9B | NOK 58.1B | NOK 2,906.09 | 1.90% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | NOK 17.7B | NOK 76B | NOK 452.44 | 2.55% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | NOK 32.3B | NOK 330.3B | NOK 812.92 | 0.32% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 38.9B | NOK 121.2B | NOK 145.33 | 1.23% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 41.9B | NOK 151.7B | NOK 2,363.90 | 1.17% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | NOK 42.3B | NOK 447.7B | NOK 3,919.60 | 2.29% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | NOK 43.9B | NOK 272.5B | NOK 376.15 | 0.10% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | NOK 56.8B | NOK 307.2B | NOK 498.16 | 1.23% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | NOK 56.8B | NOK 56.4B | NOK 82.85 | 1.10% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | NOK 59.1B | NOK 112.6B | NOK 581.35 | 2.36% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | NOK 63.6B | NOK 127.9B | NOK 255.93 | 1.99% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | NOK 68.9B | NOK 237.6B | NOK 5,579.60 | 1.59% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 76.8B | NOK 478.5B | NOK 410.12 | 0.87% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | NOK 94.3B | NOK 382B | NOK 664.35 | 0.35% down | 78% up | ||
| 47 | ViatrisVTRS · Health Care | NOK 142.8B | NOK 229.9B | NOK 200.50 | 1.00% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | NOK 179.3B | NOK 1.19T | NOK 582.03 | 2.27% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | NOK 181.2B | NOK 1.31T | NOK 5,179.38 | 0.12% down | 27% up | ||
| 50 | GSKGSK · Health Care | NOK 211B | NOK 948.7B | NOK 473.31 | 0.97% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | NOK 257.6B | NOK 12T | NOK 13,474.09 | 1.94% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | NOK 279.5B | NOK 1.7T | NOK 385.05 | 2.54% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | NOK 303.4B | NOK 958.3B | NOK 9,263.81 | 0.36% down | 36% up | ||
| 54 | NovartisNVS · Health Care | NOK 447.8B | NOK 2.86T | NOK 1,515.46 | 1.89% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | NOK 451.7B | NOK 662.4B | NOK 207.34 | 1.29% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | NOK 472.4B | NOK 2.69T | NOK 1,734.60 | 1.96% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | NOK 506B | NOK 1.75T | NOK 1,011.18 | 0.52% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | NOK 510.6B | NOK 3.34T | NOK 1,353.99 | 2.71% down | 51% up | ||
| 59 | SanofiSNY · Health Care | NOK 768.7B | NOK 1.1T | NOK 459.09 | 0.49% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | NOK 791.6B | NOK 6.43T | NOK 2,670.70 | 1.28% down | 38% up | ||
| 61 | PfizerPFE · Health Care | NOK 839.4B | NOK 1.56T | NOK 273.25 | 1.12% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7070 NOK).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-NOK 31.7B), BridgeBio Pharma (-NOK 20.3B) and Cytokinetics (-NOK 6.4B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of NOK 49.32T as of 18 Nov 2026, 16:15 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.